One case, from messy intake to filed E2B.
Follow a single adverse-event case through Quorum. The AI assembles it; your team reviews every field against its source; the audit trail records who did what, and when.
Intake from any format.
Adverse-event reports arrive as email, PDF, scanned fax, structured XML, or a call-center transcript. Quorum ingests all of them and starts a case — no manual re-keying.
- · Email, PDF, scanned image, E2B XML, transcript
- · Batch import for backlogs and migrations
- · Source documents kept and linked to the case
MedDRA coding, with confidence.
The AI extracts data, codes symptoms to MedDRA preferred terms, assesses seriousness and expectedness, and drafts the clinical narrative — each suggestion carrying a confidence indicator so reviewers know where to look first.
Click any value. See exactly where it came from.
This is the single most differentiating thing Quorum does. Every AI-generated field is click-to-source: select a value and the exact sentence, document, and page that produced it appear beside it. The reviewer is still the one who decides — they just stop retyping and start checking.
fax_report.pdf · p.1…two days after starting therapy, developed a maculo-papular rash across the trunk…
Narrative generation, on your template.
A drafted clinical narrative in your house style, built from the reviewed fields — every clause traceable to source, editable inline before approval.
E2B(R3) export, gateway-ready.
Generate a validated E2B(R3) file for the receiving regulator, with the full transmission and acknowledgement history retained on the case.
This is the screen an FDA inspector sees.
A complete, immutable who / what / when trail for every case — including which model version produced each AI suggestion, and who approved it.
| EVENT | ACTOR | MODEL / SOURCE | TIMESTAMP |
|---|---|---|---|
| MedDRA PT coded | AI suggestion | qm-coder-4.2 | 16 Jul 09:14 |
| Field approved | A. Kachinthaya | human | 16 Jul 10:02 |
| E2B(R3) generated | A. Kachinthaya | export | 16 Jul 10:05 |
Clinical-stage or commercial — one system.
Trial safety reporting with the deadlines and formats regulators expect.
Post-market case processing and aggregate reporting at volume.
See it on your case.
Bring a real, de-identified case. We'll process it end-to-end in 30 minutes.